Latest Breaking News On - Amphotericinb liposome - Page 5 : comparemela.com

WHO Calls to Reduce Cost of Drugs for Black Fungus by Angela Mohan on  July 2, 2021 at 11:32 AM The World Health Organization (WHO) called on to reduce the prices of the drug used to treat black fungus due to COVID-19. Developed by California-based drugmaker Gilead Sciences, AmBisome is a lipid-based amphotericin, used to treat the black fungus infections, which starts in the nose and quickly spreads to the eyes and brain. The WHO has urged the company to lower its prices as well as boost supplies to curb the rapidly rising cases in South Asia, the Financial Times reported. An immediate strategy for broadening supply and improving affordability of lipid-based amphotericin is to integrate it into the existing COVID-19 response and for Gilead to extend their existing lower pricing arrangement to Covid patients, Who s Assistant Director General for access to medicines, Mariangela Simao, was quoted as saying.

Mariangela simaoCentral drugs standard control organizationAssistant director generalMedecins sans frontieresAmphotericinb liposomeமைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்உதவியாளர் இயக்குனர் ஜநரல்மேதேசின்ஸ் சான்ஸ் எல்லைகள்